Lipid Peroxidation-Derived DNA Adducts and the Role in Inflammation-Related Carcinogenesis

Cancer and Inflammation Mechanisms: Chemical, Biological, and Clinical Aspects

Volumn , Issue , 2014, Pages 61-74

  Bartsch, Helmut ^a   Nair, Urmila Jagadeesan ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Carcinogenesis; DNA adducts; DNA damage; Inflammation related malignancies; Lipid peroxidation (LPO); Oxidative nitrative stress

Indexed keywords

EID: 84912136297     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118826621.ch5     Document Type: Chapter

References (56)

1. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-867.
2. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003; 3: 276-285.
3. Kawanishi S, Hiraku Y. Oxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to inflammation. Antioxid Redox Signal 2006; 8: 1047-1058.
4. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008; 454: 436-444.
5. Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 1994; 305: 253-264.
6. Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005; 5: 749-759.
7. Inoue S, Kawanishi S. Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide. FEBS Lett 1995; 371: 86-88.
8. Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 2007; 121: 2373-2380.
9. Lonkar P, Dedon PC. Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates. Int J Cancer 2011; 128: 1999-2009.
10. Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006; 124: 823-835.
11. Ohshima H, Sawa T, Akaike T. 8-Nitroguanine, a product of nitrative DNA damage caused by reactive nitrogen species: formation, occurrence, and implications in inflammation and carcinogenesis. Antioxid Redox Signal 2006; 8: 1033-1045.
12. Marnett LJ. Oxy radicals, lipid peroxidation and DNA damage. Toxicology 2002; 181-182: 219-222.
13. West JD, Marnett LJ. Endogenous reactive intermediates as modulators of cell signaling and cell death. Chem Res Toxicol 2006; 19: 173-194.
14. Nair U, Bartsch H, Nair J. Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: a review of published adduct types and levels in humans. Free Radic Biol Med 2007; 43: 1109-1120.
15. Barbin A. Etheno-adduct-forming chemicals: from mutagenicity testing to tumor mutation spectra. Mutat Res 2000; 462: 55-69.
16. Bartsch H, Nair J. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair. Langenbecks Arch Surg 2006; 391: 499-510.
17. Virchow R. Die krankhaften Geschwülste: Dreissig Vorlesungen gehalten während des Wintersemesters 1862-1863 an der Universität zu Berlin. Berlin: Verlag August Hirschwald; 1863.
18. Nair J, De FS, Izzotti A, Bartsch H. Lipid peroxidation-derived etheno-DNA adducts in human atherosclerotic lesions. Mutat Res 2007; 621: 95-105.
19. DeFlora S, Izzotti A, Randerath K, Randerath E, Bartsch H, Nair J, et al. DNA adducts and chronic degenerative disease: pathogenetic relevance and implications in preventive medicine. Mutat Res 1996; 366: 197-238.
20. Blair IA. DNA adducts with lipid peroxidation products. J Biol Chem 2008; 283: 15545-15549.
21. Dedon PC, DeMott MS, Elmquist CE, Prestwich EG, McFaline JL, Pang B. Challenges in developing DNA and RNA biomarkers of inflammation. Biomark Med 2007; 1: 293-312.
22. Pang B, Zhou X, Yu H, Dong M, Taghizadeh K, Wishnok JS, et al. Lipid peroxidation dominates the chemistry of DNA adduct formation in a mouse model of inflammation. Carcinogenesis 2007; 28: 1807-1813.
23. Chen HJ, Lin WP. Quantitative analysis of multiple exocyclic DNA adducts in human salivary DNA by stable isotope dilution nanoflow liquid chromatography-nanospray ionization tandem mass spectrometry. Anal Chem 2011; 83: 8543-8551.
24. Medeiros MH. Exocyclic DNA adducts as biomarkers of lipid oxidation and predictors of disease: challenges in developing sensitive and specific methods for clinical studies. Chem Res Toxicol 2009; 22: 419-425.
25. Nair J, Nair UJ, Sun X, Wang Y, Arab K, Bartsch H. Quantifying etheno-DNA adducts in human tissues, white blood cells, and urine by ultrasensitive (32)P-postlabeling and immunohistochemistry. Methods Mol Biol 2011; 682: 189-205.
26. Nair J, Strand S, Frank N, Knauft J, Wesch H, Galle PR, et al. Apoptosis and age-dependent induction of nuclear and mitochondrial etheno-DNA adducts in Long-Evans Cinnamon (LEC) rats: enhanced DNA damage by dietary curcumin upon copper accumulation. Carcinogenesis 2005; 26: 1307-1315.
27. Nair J, Godschalk RW, Nair U, Owen RW, Hull WE, Bartsch H. Identification of 3,N(4)-etheno-5-methyl-2′-deoxycytidine in human DNA: a new modified nucleoside which may perturb genome methylation. Chem Res Toxicol 2012; 25: 162-169.
28. Robertson KD. DNA methylation and human disease. Nat Rev Genet 2005; 6: 597-610.
29. Nair J, Vaca CE, Velic I, Mutanen M, Valsta LM, Bartsch H. High dietary omega-6 polyunsaturated fatty acids drastically increase the formation of etheno-DNA base adducts in white blood cells of female subjects. Cancer Epidemiol Biomark Prev 1997; 6: 597-601.
30. Nair J, Gal A, Tamir S, Tannenbaum SR, Wogan GN, Bartsch H. Etheno adducts in spleen DNA of SJL mice stimulated to overproduce nitric oxide. Carcinogenesis 1998; 19: 2081-2084.
31. Nair J, Furstenberger G, Burger F, Marks F, Bartsch H. Promutagenic etheno-DNA adducts in multistage mouse skin carcinogenesis: correlation with lipoxygenase-catalyzed arachidonic acid metabolism. Chem Res Toxicol 2000; 13: 703-709.
32. Schmid K, Nair J, Winde G, Velic I, Bartsch H. Increased levels of promutagenic etheno-DNA adducts in colonic polyps of FAP patients. Int J Cancer 2000; 87: 1-4.
33. Yongvanit P, Pinlaor S, Bartsch H. Oxidative and nitrative DNA damage: key events in opisthorchiasis-induced carcinogenesis. Parasitol Int 2012; 61: 130-135.
34. Dechakhamphu S, Yongvanit P, Nair J, Pinlaor S, Sitthithaworn P, Bartsch H. High excretion of etheno adducts in liver fluke-infected patients: protection by praziquantel against DNA damage. Cancer Epidemiol Biomark Prev 2008; 17: 1658-1664.
35. Bartsch H, Kuroki T, Malaveille C, Loprieno N, Barale R, Abbondandolo A, et al. Absence of mutagenicity of praziquantel, a new, effective, anti-schistosomal drug, in bacteria, yeasts, insects and mammalian cells. Mutat Res 1978; 58: 133-142.
36. Dechakhamphu S, Pinlaor S, Sitthithaworn P, Nair J, Bartsch H, Yongvanit P. Lipid peroxidation and etheno DNA adducts in white blood cells of liver fluke-infected patients: protection by plasma alpha-tocopherol and praziquantel. Cancer Epidemiol Biomark Prev 2010; 19: 310-318.
37. Dechakhamphu S, Pinlaor S, Sitthithaworn P, Bartsch H, Yongvanit P. Accumulation of miscoding etheno-DNA adducts and highly expressed DNA repair during liver fluke-induced cholangiocarcinogenesis in hamsters. Mutat Res 2010; 691: 9-16.
38. Brechot C. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 2004; 127: S56-S61.
39. Loguercio C, Federico A. Oxidative stress in viral and alcoholic hepatitis. Free Radic Biol Med 2003; 34: 1-10.
40. Nair J, Srivatanakul P, Haas C, Jedpiyawongse A, Khuhaprema T, Seitz HK, et al. High urinary excretion of lipid peroxidation-derived DNA damage in patients with cancer-prone liver diseases. Mutat Res 2010; 683: 23-28.
41. Bartsch H, Nair J. Accumulation of lipid peroxidation-derived DNA lesions: potential lead markers for chemoprevention of inflammation-driven malignancies. Mutat Res 2005; 591: 34-44.
42. Frank A, Seitz HK, Bartsch H, Frank N, Nair J. Immunohistochemical detection of 1,N6-ethenodeoxyadenosine in nuclei of human liver affected by diseases predisposing to hepatocarcinogenesis. Carcinogenesis 2004; 25: 1027-1031.
43. Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 2007; 7: 599-612.
44. Wang Y, Millonig G, Nair J, Patsenker E, Stickel F, Mueller S, et al. Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease. Hepatology 2009; 50: 453-461.
45. Zarkovic N. 4-Hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Aspects Med 2003; 24: 281-291.
46. Secretan B, Straif K, Baan R, Grosse Y, El GF, Bouvard V, et al. A review of human carcinogens-Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009; 10: 1033-1034.
47. Millonig G, Wang Y, Homann N, Bernhardt F, Qin H, Mueller S, et al. Ethanol-mediated carcinogenesis in the human esophagus implicates CYP2E1 induction and the generation of carcinogenic DNA-lesions. Int J Cancer 2011; 128: 533-540.
48. Borgna-Pignatti C, Vergine G, Lombardo T, Cappellini MD, Cianciulli P, Maggio A, et al. Hepatocellular carcinoma in the thalassaemia syndromes. Br J Haematol 2004; 124: 114-117.
49. Meerang M, Nair J, Sirankapracha P, Thephinlap C, Srichairatanakool S, Fucharoen S, et al. Increased urinary 1,N6-ethenodeoxyadenosine and 3,N4-ethenodeoxycytidine excretion in thalassemia patients: markers for lipid peroxidation-induced DNA damage. Free Radic Biol Med 2008; 44: 1863-1868.
50. Meerang M, Nair J, Sirankapracha P, Thephinlap C, Srichairatanakool S, Arab K, et al. Accumulation of lipid peroxidation-derived DNA lesions in iron-overloaded thalassemic mouse livers: comparison with levels in the lymphocytes of thalassemia patients. Int J Cancer 2009; 125: 759-766.
51. Nair J, Carmichael PL, Fernando RC, Phillips DH, Strain AJ, Bartsch H. Lipid peroxidation-induced etheno-DNA adducts in the liver of patients with the genetic metal storage disorders Wilson's disease and primary hemochromatosis. Cancer Epidemiol Biomark Prev 1998; 7: 435-440.
52. Nair J, Gansauge F, Beger H, Dolara P, Winde G, Bartsch H. Increased etheno-DNA adducts in affected tissues of patients suffering from Crohn's disease, ulcerative colitis, and chronic pancreatitis. Antioxid Redox Signal 2006; 8: 1003-1010.
53. Hanaoka T, Nair J, Takahashi Y, Sasaki S, Bartsch H, Tsugane S. Urinary level of 1,N(6)-ethenodeoxyadenosine, a marker of oxidative stress, is associated with salt excretion and omega 6-polyunsaturated fatty acid intake in postmenopausal Japanese women. Int J Cancer 2002; 100: 71-75.
54. Nair J, Barbin A, Guichard Y, Bartsch H. 1,N6-ethenodeoxyadenosine and 3,N4-ethenodeoxycytine in liver DNA from humans and untreated rodents detected by immunoaffinity/32P-postlabeling. Carcinogenesis 1995; 16: 613-617.
55. Nair J. Lipid peroxidation-induced etheno-DNA adducts in humans. IARC Sci Publ 1999;55-61.
56. Sun X, Karlsson A, Bartsch H, Nair J. New ultrasensitive 32P-postlabelling method for the analysis of 3,N4-etheno-2′-deoxycytidine in human urine. Biomarkers 2006; 11: 329-340.